| No. | PI | Scheme | Ref. | Period | Title | Funded amount | Currency |
| 1 | Dr. LIU, Jin | RGC-GRF | 12106924 | 01/09/2024-31/03/2027 | Targeting osteoblastic 11β-HSD1 to combat high fat diet-induced bone loss, glucose handing impairment and obesity | 1,559,514 | HKD |
| 2 | Prof. ZHANG Ge | ITF | GHP/149/21GD | 03/10/2023-26/01/2025 | Development of Small-molecule Inhibitors Targeting Sclerostin Loop3 for Osteoporosis | 1,999,850 | HKD |
| 3 | Prof. ZHANG Ge | ITF | PiH/356/23 | 03/10/2023-26/01/2025 | Development of Small-molecule Inhibitors Targeting Sclerostin Loop4 for Osteoporosis | 733,838.71 | HKD |
| 4 | Prof. ZHANG Ge | ITF | PiH/466/23 | 15/09/2023-31/03/2025 | Development of Small-molecule Inhibitors Targeting Sclerostin Loop5 for Osteoporosis | 846,450.00 | HKD |
| 5 | Prof. ZHANG Ge | ITF | PiH/432/23 | 01/09/2023-31/08/2024 | Development of Small-molecule Inhibitors Targeting Sclerostin Loop6 for Osteoporosis | 558,000.00 | HKD |
| 6 | Prof. ZHANG, Ge | RGC-GRF | 12102223 | 01/01/2024-31/12/2026 | Macrophagic sclerostin loop2-ApoER2 interaction participates in the suppressive effect of sclerostin on atherosclerosis | 1,598,500 | HKD |
| 7 | Prof. ZHANG, Ge | RGC-GRF | 12100921 | 01/01/2022-30/06/2025 | A next generation of sclerostin inhibitor with bone anabolic potential and without increasing cardiovascular risk for osteogenesis imperfecta: How does sclerostin loop3-specific aptamer work? | 1,159,228 | HKD |
| 8 | Prof. ZHANG, Ge | RGC-GRF | 12102524 | 01/01/2025-31/12/2027 | Osteoblastic sclerostin loop3-LRP4 interaction could be required by sclerostin to inhibit bone formation | 1,364,633 | HKD |
| 9 | Prof. ZHANG, Ge | 深港澳科技计划 | SGDX20230821095359002 | 24/05/2024-23/05/2026 | 硬骨抑素特定结构区loop3在模拟失重导致的骨形成降低和区域性动脉僵硬度升高中的功能研究 | 3,000,000 | HKD |
| 10 | Prof. ZHANG, Ge | 广东省基础与应用基础研究基金项目 | 2019B1515120089 | 01/01/2020-31/12/2022 | 骨硬化素loop3适配子的促骨形成潜能：分子机理及转化研究 | 1,000,000 | HKD |
| 11 | Dr. YU Sifan | NFSC | 82304378 | 01/01/2024-31/12/2026 | Studies on the mechanism of long-lasting modification combined two small molecules: taking the dual-modified sclerostin apatmer as an example | 300,000 | RMB |
| 12 | Prof.LYU, Aiping | TRS | T12-201/20-R | 01/01/2021 - 31/12/2025 | Aptamer: Molecular Insight & Translational Theranostics | ||
| 13 | Dr YU, Yuanyuan | RGC-GRF | 12102120 | 01/01/2021 - 30/06/2023 | Targeting sclerostin loop3 to promote bone formation with low cardiovascular risk in animal models | ||
| 14 | Dr YU, Yuanyuan | RGC-GRF | 12102322 | 01/01/2023 - 31/12/2025 | The role of the interactions between N domain and Linker 2 of DKK1 in modulating the immunosuppressive tumor microenvironment mediated by DKK1 C domain | ||
| 15 | Dr. WANG Luyao | NSFC | 82300988 | 01/01/2024-31/12/2026 | Macrophagic sclerostin loop2-ApoER2 interaction required by sclerostin for atherosclerosis suppressive action |